1. |
Anwar SL, Avanti WS, Dwianingsih EK, et al. Risk factors, patterns, and distribution of bone metastases and skeletal-related events in high-risk breast cancer patients. Asian Pac J Cancer Prev, 2022, 23(12): 4109-4117.
|
2. |
Pantel K, Hayes DF. Disseminated breast tumour cells: biological and clinical meaning. Nat Rev Clin Oncol, 2018, 15(3): 129-131.
|
3. |
Coleman RE, Smith P, Rubens RD. Clinical course and prognostic factors following bone recurrence from breast cancer. Br J Cancer, 1998, 77(2): 336-340.
|
4. |
李奕颖, 苏静, 李孟圈. 乳腺癌骨转移的影响因素分析及预测模型构建. 河南医学研究, 2021, 30(2): 211-215.
|
5. |
章锐, 阮剑, 赵建国. 基于SEER数据库构建的远处转移性乳腺癌的预后列线图. 安徽医药, 2022, 26(9): 1781-1785.
|
6. |
Ye LJ, Suo HD, Liang CY, et al. Nomogram for predicting the risk of bone metastasis in breast cancer: a SEER population-based study. Transl Cancer Res, 2020, 9(11): 6710-6719.
|
7. |
Makhoul I, Montgomery CO, Gaddy D, et al. The best of both worlds—managing the cancer, saving the bone. Nat Rev Endocrinol, 2016, 12(1): 29-42.
|
8. |
Wang R, Zhu Y, Liu X, et al. The clinicopathological features and survival outcomes of patients with different metastatic sites in stage Ⅳ breast cancer. BMC, Cancer, 2019, 19(1): 1091.
|
9. |
Klein CA. Parallel progression of primary tumours and metastases. Nat Rev Cancer, 2009, 9(4): 302-312.
|
10. |
孟红霞, 张浩强, 乔永杰, 等. 唑来膦酸联合放射治疗对乳腺癌骨转移的疗效. 临床与病理杂志, 2018, 38(7): 1463-1468.
|
11. |
中国抗癌协会骨肿瘤和骨转移瘤专业委员会. 乳腺癌骨转移临床诊疗专家共识. 中国肿瘤临床, 2022, 49(13): 660-669.
|
12. |
DeSantis CE, Fedewa SA, Goding Sauer A, et al. Breast cancer statistics, 2015: convergence of incidence rates between black and white women. CA Cancer J Clin, 2016, 66(1): 31-42.
|
13. |
Diessner J, Wischnewsky M, Stüber T, et al. Evaluation of clinical parameters influencing the development of bone metastasis in breast cancer. BMC Cancer, 2016, 16: 307. doi: 10.1186/s12885-016-2345-7.
|
14. |
Koizumi M, Yoshimoto M, Kasumi F, et al. An open cohort study of bone metastasis incidence following surgery in breast cancer patients. BMC Cancer, 2010, 10: 381.
|
15. |
Pulido C, Vendrell I, Ferreira AR, et al. Bone metastasis risk factors in breast cancer. Ecancermedicalscience, 2017, 11: 715. doi: 10.3332/ecancer.2017.715.
|
16. |
Ma W, Wang X, Xu G, et al. Distant metastasis prediction via a multi-feature fusion model in breast cancer. Aging (Albany NY), 2020, 12(18): 18151-18162.
|
17. |
Chen J, Zhu S, Xie XZ, et al. Analysis of clinicopathological factors associated with bone metastasis in breast cancer. J Huazhong Univ Sci Technolog Med Sci, 2013, 33(1): 122-125.
|
18. |
Hofbauer LC, Rachner TD, Coleman RE, et al. Endocrine aspects of bone metastases. Lancet Diabetes Endocrinol, 2014, 2(6): 500-512.
|
19. |
Hinz N, Baranowsky A, Horn M, et al. Knockdown of AKT3 activates HER2 and DDR kinases in bone-seeking breast cancer cells, promotes metastasis in vivo and attenuates the TGFβ/CTGF axis. Cells, 2021, 10(2): 430.
|
20. |
Korde LA, Gralow JR. Can we predict who’s at risk for developing bone metastases in breast cancer?. J Clin Oncol, 2011, 29(27): 3600-3604.
|
21. |
Xiong Z, Deng G, Huang X, et al. Bone metastasis pattern in initial metastatic breast cancer: a population-based study. Cancer Manag Res, 2018, 10: 287-295.
|
22. |
Yang L, Du W, Hu T, et al. Survival in breast cancer patients with bone metastasis: a multicenter real-world study on the prognostic impact of intensive postoperative bone scan after initial diagnosis of breast cancer (CSBrS-023). Cancers (Basel), 2022, 14(23): 5835.
|
23. |
James JJ, Evans AJ, Pinder SE, et al. Bone metastases from breast carcinoma: histopathological-radiological correlations and prognostic features. Br J Cancer, 2003, 89(4): 660-665.
|
24. |
Smid M, Wang Y, Klijn JG, et al. Genes associated with breast cancer metastatic to bone. J Clin Oncol, 2006, 24(15): 2261-2267.
|